📊 Get daily AI-graded market briefings
Morning + evening · AI impact + sector exposure · Free
HOME › COVERAGE › ASCLF › EARNINGS
EARNINGS HUB
News Coverage Earnings Hub Earnings Report Grades
$ASCLF
0 quarters of earnings history
LAST 30 DAYS
1 articles
AVG GRADE
HIGH
score: 1.00
SENTIMENT
—
TOTAL VIEWS
6
◆ EPS MOMENTUM
PERIOD
ACTUAL EPS
ESTIMATE
SURPRISE
No earnings data for ASCLF.
◈ RELATED EARNINGS NEWS
manilatimes.
2026-07-15
Ascletis Selects for Clinical Development a Fixed-Dose Combination of First-in-Class Oral Small Molecule GIPR Agonist, ASC48, and Oral Small Molecule GLP-1R Agonist, ASC30
NEUTRAL
manilatimes.
2026-06-23
Ascletis Announces U.S. FDA IND Clearance for Phase I Study of Once-Monthly Subcutaneously Administered GLP-1R/GIPR Dual Peptide Agonist, ASC35, for the Treatment of Obesity
HIGH
 View all ASCLF news →
NEWS-BASED SECTOR EXPOSURE ANALYSISPOWERED BY CLAUDE HAIKU 4.5NOT INVESTMENT ADVICE
E
ESEN Analytics
AI-powered equity research platform covering 5,000+ US equities. Our proprietary AI grading system (A+ to D scale) analyzes fundamentals, technicals, and news sentiment daily. Coverage data updated every 24 hours. Learn about our methodology →
ⓘ AI-graded news coverage · Not investment advice